Johannes Kreuzer

7PUBLICATIONS
116CO-AUTHORS
Molecular targetsReproductionCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 02, 2026
CDK2 Inhibition Exerts RB-Independent Antitumor Activity in CDK4/6 Inhibitor-Resistant HR+/HER2- Breast Cancer.

|Jul 17, 2025
Decoding protein phosphorylation during oocyte meiotic divisions using phosphoproteomics.

Leonid Peshkin, Enrico Maria Daldello, Elizabeth S Van Itallie

|Jul 07, 2025
CDKN1B (p27/kip1) enhances drug-tolerant persister CTCs by restricting polyploidy following mitotic inhibitors.

Elad Horwitz, Taronish D Dubash, Annamaria Szabolcs

|May 12, 2025
Generation of a Biliary Tract Cancer Cell Line Atlas Identifies Molecular Subtypes and Therapeutic Targets.

Vindhya Vijay, Negin Karisani, Lei Shi

|Oct 28, 2022
Ribosome changes reprogram translation for chemosurvival in G0 leukemic cells.

Chandreyee Datta, Samuel S Truesdell, Keith Q Wu

|Jun 03, 2022
CD4+ T helper 2 cells suppress breast cancer by inducing terminal differentiation.

Margherita Boieri, Anna Malishkevich, Ranya Guennoun

Pageof 2

Frequent Collaborators

5 joint publications

Wilhelm Haas

2 joint publications

Michael S Lawrence

2 joint publications

Dejan Juric

2 joint publications

Robert Morris